71 related articles for article (PubMed ID: 8320910)
1. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients.
Caillat-Zucman S; Gimenez JJ; Albouze G; Lebkiri B; Naret C; Jungers P; Bach JF
Kidney Int Suppl; 1993 Jun; 41():S157-60. PubMed ID: 8320910
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine.
Amirzargar AA; Mohseni N; Shokrgozar MA; Arjang Z; Ahmadi N; Yousefi Behzadi M; Amanzadeh A; Shokri F
Iran J Immunol; 2008 Jun; 5(2):92-9. PubMed ID: 18523354
[TBL] [Abstract][Full Text] [Related]
3. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.
Caillat-Zucman S; Gimenez JJ; Wambergue F; Albouze G; Lebkiri B; Naret C; Moynot A; Jungers P; Bach JF
Kidney Int; 1998 Jun; 53(6):1626-30. PubMed ID: 9607193
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
5. The contribution of HLA-Class II antigens in humoral non-response and delayed response to HBsAG vaccination.
Vidan-Jeras B; Brinovec V; Jurca B; Levicnik Steyinar S; Jeras M; Bohinjec M
Pflugers Arch; 2000; 440(5 Suppl):R188-9. PubMed ID: 11005666
[TBL] [Abstract][Full Text] [Related]
6. Genetic prediction of nonresponse to hepatitis B vaccine.
Alper CA; Kruskall MS; Marcus-Bagley D; Craven DE; Katz AJ; Brink SJ; Dienstag JL; Awdeh Z; Yunis EJ
N Engl J Med; 1989 Sep; 321(11):708-12. PubMed ID: 2528067
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
8. [Association of immune response to hepatitis B vaccine with HLA-DRB1*02, 07, 09 genes in the population of Han nationality in Guangdong Province].
Qian Y; Zhang L; Liang XM; Hou JL; Luo KX
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):67-9. PubMed ID: 12390851
[TBL] [Abstract][Full Text] [Related]
9. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.
Martinetti M; De Silvestri A; Belloni C; Pasi A; Tinelli C; Pistorio A; Salvaneschi L; Rondini G; Avanzini MA; Cuccia M
Clin Immunol; 2000 Dec; 97(3):234-40. PubMed ID: 11112362
[TBL] [Abstract][Full Text] [Related]
10. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.
Stanevicha V; Eglite J; Zavadska D; Sochnevs A; Shantere R; Gardovska D
Arthritis Res Ther; 2007; 9(3):R58. PubMed ID: 17559688
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetic susceptibility to diabetes mellitus in patients with liver disease.
Montano-Loza AJ; Sultan A; Falanga D; Loss G; Mason AL
Liver Int; 2009 Nov; 29(10):1543-51. PubMed ID: 19663932
[TBL] [Abstract][Full Text] [Related]
12. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
Lin HH; Liao HW; Lin SK; Wang LY
Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
[TBL] [Abstract][Full Text] [Related]
13. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of hepatitis B--HLA DR/DQ in HBs Ag nonresponder].
Ouchi E; Hoshino A; Miura T; Nagahara N; Kudo Y; Tamura M
Rinsho Byori; 1989 Nov; 37(11):1193-9. PubMed ID: 2601078
[TBL] [Abstract][Full Text] [Related]
15. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
16. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition.
Pando M; Larriba J; Fernandez GC; Fainboim H; Ciocca M; Ramonet M; Badia I; Daruich J; Findor J; Tanno H; Cañero-Velasco C; Fainboim L
Hepatology; 1999 Dec; 30(6):1374-80. PubMed ID: 10573514
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.
Chauhan B; Santiago L; Hutcheson PS; Schwartz HJ; Spitznagel E; Castro M; Slavin RG; Bellone CJ
J Allergy Clin Immunol; 2000 Oct; 106(4):723-9. PubMed ID: 11031343
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
19. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production.
Zuckerman JN
J Med Virol; 1996 Dec; 50(4):283-8. PubMed ID: 8950683
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.
Bittencourt PL; Goldberg AC; Cançado EL; Porta G; Carrilho FJ; Farias AQ; Palacios SA; Chiarella JM; Abrantes-Lemos CP; Baggio VL; Laudanna AA; Kalil J
Am J Gastroenterol; 1999 Jul; 94(7):1906-13. PubMed ID: 10406258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
